tiprankstipranks
Advertisement
Advertisement

DE:4AB Stock Latest News

AbbVie submits Skyrizi application to the EMA
The FlyAbbVie submits Skyrizi application to the EMA
22h ago
ABBV
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
2d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
3d ago
ABT
BMY
AbbVie price target raised to $303 from $298 at Piper Sandler
PremiumThe Fly
AbbVie price target raised to $303 from $298 at Piper Sandler
8d ago
ABBV
AbbVie Raises $9 Billion Debt to Fund Acquisition
PremiumCompany Announcements
AbbVie Raises $9 Billion Debt to Fund Acquisition
9d ago
8K
ABBV
AbbVie price target raised to $300 from $295 at Wells Fargo
PremiumThe FlyAbbVie price target raised to $300 from $295 at Wells Fargo
11d ago
ABBV
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
11d ago
ABBV
Apogee Therapeutics price target raised to $135 from $81 at Truist
Premium
The Fly
Apogee Therapeutics price target raised to $135 from $81 at Truist
11d ago
ABBV
APGE
AbbVie price target raised to $260 from $246 at Evercore ISI
PremiumThe Fly
AbbVie price target raised to $260 from $246 at Evercore ISI
18d ago
ABBV
AbbVie prices $9.9B senior notes to fund acquisition
PremiumCompany Announcements
AbbVie prices $9.9B senior notes to fund acquisition
22d ago
8K
ABBV
AbbVie upgraded to Buy from Hold at Erste Group
PremiumThe Fly
AbbVie upgraded to Buy from Hold at Erste Group
23d ago
ABBV
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
PremiumThe Fly
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
24d ago
ABBV
AbbVie’s Allergan Aesthetics receives FDA approval of sBLA for Botox Cosmetic
PremiumThe FlyAbbVie’s Allergan Aesthetics receives FDA approval of sBLA for Botox Cosmetic
24d ago
ABBV
AbbVie price target raised to $288 from $261 at Guggenheim
Premium
The Fly
AbbVie price target raised to $288 from $261 at Guggenheim
24d ago
ABBV
AbbVie price target raised to $285 from $265 at Cantor Fitzgerald
Premium
The Fly
AbbVie price target raised to $285 from $265 at Cantor Fitzgerald
25d ago
ABBV
AbbVie price target raised to $296 from $278 at Morgan Stanley
PremiumThe Fly
AbbVie price target raised to $296 from $278 at Morgan Stanley
25d ago
ABBV
AbbVie price target raised to $290 from $282 at Canaccord
PremiumThe Fly
AbbVie price target raised to $290 from $282 at Canaccord
25d ago
ABBV
AbbVie Earnings Call: Growth Engines Outpace Legacy Drag
PremiumCompany Announcements
AbbVie Earnings Call: Growth Engines Outpace Legacy Drag
27d ago
ABBV
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
PremiumThe Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
28d ago
CL
BSX
AbbVie says ‘quite pleased’ with Skyrizi momentum
PremiumThe FlyAbbVie says ‘quite pleased’ with Skyrizi momentum
28d ago
ABBV
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
Premium
The Fly
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
28d ago
ABBV
AbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
Premium
The Fly
AbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
28d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >